WATSON 822 (Naproxen 375 mg)
Pill imprint WATSON 822 has been identified as Naproxen 375 mg.
Naproxen is used in the treatment of back pain; sciatica; gout, acute; ankylosing spondylitis; muscle pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Naproxen 375 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WATSON 822
- Strength:
- 375 mg
- Color:
- Gray
- Size:
- 14.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0822
- Inactive Ingredients:
- croscarmellose sodium
magnesium stearate
povidone
synthetic ferric oxide black
synthetic ferric oxide red
synthetic ferric oxide yellow
More about naproxen
Consumer resources
- Naproxen
- Naproxen enteric-coated tablets
- Naproxen suspension
- Naproxen sustained-release tablets
- Naproxen tablets and capsules
- Naproxen (Advanced Reading)
- Other brands: Aleve, Naprosyn, Anaprox, Anaprox-DS, More (6) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
